FDA approves bispecific drug from Pfizer for multiple myeloma

[cafead]

via The Food and Drug Administration on Monday granted accelerated approval to Pfizer’s Elrexfio for people with advanced multiple myeloma, making it the third drug of its type to treat the blood cancer.

article source